WAYNE, Pa.--(BUSINESS WIRE)--March 21, 2006--Covalent Group, Inc. (Nasdaq: CVGR) ("Covalent"), a leader in the design and management of complex clinical trials and patient disease registries for the pharmaceutical, biotechnology and medical device industries, today announced its financial results for the fourth quarter and year ended December 31, 2005 (see attached tables).
